CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $3.5B, above the global median of $1.18B
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
336.22BINR3.50B · vs all stocks (USD)
Trailing P/E
92.89xvs Diagnostics & Research peers
Revenue (TTM)
22.50BINR234.51M · vs all stocks (USD)
Profit Margin
16.07%vs Diagnostics & Research peers
52-Week Change
82.29%vs all stocks
Market Capitalization
336.22BINR3.50B · vs all stocks (USD)
Enterprise Value
336.55BINR3.51B · vs all stocks (USD)
Trailing P/E
92.89xvs Diagnostics & Research peers
Forward P/E
63.35xvs Diagnostics & Research peers
PEG Ratio
-5.05xvs Diagnostics & Research peers
Price to Sales (TTM)
14.94xvs Diagnostics & Research peers
Price to Book (MRQ)
13.47xvs Diagnostics & Research peers
Enterprise to Revenue
14.96xvs Diagnostics & Research peers
Enterprise to EBITDA
50.27xvs Diagnostics & Research peers
Gross Margin
41.40%vs Diagnostics & Research peers
Profit Margin
16.07%vs Diagnostics & Research peers
Operating Margin
18.41%vs Diagnostics & Research peers
Return on Assets (TTM)
9.62%vs Diagnostics & Research peers
Return on Equity (TTM)
14.05%vs Diagnostics & Research peers
Revenue (TTM)
22.50BINR234.51M · vs all stocks (USD)
Revenue per Share (TTM)
106.83INRUpdated Sep 29, 2026Quarterly Revenue Growth
11.70%vs Diagnostics & Research peers
Gross Profit (TTM)
16.76BINR174.62M · vs all stocks (USD)
EBITDA (TTM)
6.71BINR69.89M · vs all stocks (USD)
Net Income (TTM)
3.62BINR37.70M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
21.20%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
5.09BINR53.06M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.49BINR36.36M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00INRUpdated Sep 29, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
21.92BINRFY2026 · Mar 31, 2026Cost of Goods Sold
12.54BINRFY2026 · Mar 31, 2026Gross Profit
9.39BINRFY2026 · Mar 31, 2026Operating Income
4.64BINR48.39M · vs all stocks (USD)
Pre-tax Income
4.66BINRFY2026 · Mar 31, 2026Income Tax Expense
1.17BINRFY2026 · Mar 31, 2026Net Income
3.49BINRFY2026 · Mar 31, 2026EBIT
5.05BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
6.80BINRFY2026 · Mar 31, 2026Other Operating Expenses
3.07BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
392.39MINRFY2026 · Mar 31, 2026EPS (Basic)
16.63INRFY2026 · Mar 31, 2026EPS (Diluted)
16.43INRFY2026 · Mar 31, 2026Basic Shares Outstanding
209.81MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
209.81MSharesFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
3.82BINRFY2026 · Mar 31, 2026Free Cash Flow
-2.10BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
819.14MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
4.66BINRFY2026 · Mar 31, 2026Stock-based Compensation
21.04MINRFY2026 · Mar 31, 2026Other Non-cash Items
206.21MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-154.17MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-910.87MINRFY2026 · Mar 31, 2026Capital Expenditures
-5.92BINRFY2026 · Mar 31, 2026Net Acquisitions
-15.67MINRFY2026 · Mar 31, 2026Purchase of Investments
-1.16BINRFY2026 · Mar 31, 2026Sale of Investments
2.92BINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-4.18BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
255.04MINRFY2026 · Mar 31, 2026Long-term Debt Payments
0.00INRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
-588.90MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-82.92MINRFY2026 · Mar 31, 2026Shares Outstanding
212.42MSharesUpdated Sep 29, 2026Float Shares
128.86MSharesUpdated Sep 29, 2026% Held by Insiders
37.89%vs all stocks
% Held by Institutions
44.87%vs all stocks
Total Cash (MRQ)
1.58BINR16.45M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.45INRUpdated Sep 29, 2026Total Debt (MRQ)
2.88BINR30.06M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1161xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.69xvs Diagnostics & Research peers
Book Value per Share (MRQ)
117.47INRUpdated Sep 29, 2026Total Assets
36.26BINR377.88M · vs all stocks (USD)
Total Current Assets
14.11BINRFY2026 · Mar 31, 2026Total Liabilities
11.42BINRFY2026 · Mar 31, 2026Total Non-current Assets
22.16BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
3.09BINRFY2026 · Mar 31, 2026Total Current Liabilities
8.34BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
819.14MINRFY2026 · Mar 31, 2026Other Short-term Investments
1.80BINRFY2026 · Mar 31, 2026Accounts Receivable
3.74BINRFY2026 · Mar 31, 2026Inventory
1.51BINRFY2026 · Mar 31, 2026Accounts Payable
2.85BINRFY2026 · Mar 31, 2026Short-term Debt
1.40BINRFY2026 · Mar 31, 2026Other Current Liabilities
1.73BINRFY2026 · Mar 31, 2026Long-term Debt
1.48BINRFY2026 · Mar 31, 2026Common Stock (Book)
211.78MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
24.84BINR258.83M · vs all stocks (USD)
52-Week Low
783.85INRUpdated Sep 29, 202652-Week High
1.70KINRUpdated Sep 29, 202652-Week Change
82.29%vs all stocks
50-Day MA
1.46KINRUpdated Sep 29, 2026200-Day MA
1.14KINRUpdated Sep 29, 2026Avg 10-Day Volume
451.32KSharesUpdated Sep 29, 2026Avg 30-Day Volume
704.19KSharesUpdated Sep 29, 2026Diluted EPS (TTM)
17.04INRUpdated Sep 29, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $3.5B, above the global median of $1.18BNotable
Market cap (USD): 3,503,702,381.033Global Median: 1,180,223,658.953
Levered free cash flow is $36.36M, above the global median of $18.73MNotable
Levered free cash flow (USD): 36,359,911.1Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
PVH Corp.
Tier 1ProductionThroughput-Bound ConversionFlowAttention
Fujian Torch Electron Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ultra Clean Holdings, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Aiko Solar Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
Lily Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ta Chen Stainless Pipe Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
HFCL Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fulin Precision Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hefei Chipmore Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Himadri Speciality Chemical Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Lontium Semiconductor Corp.
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue And Profit Growth
Hainan Jinpan Smart Technology Co., Ltd.
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue And Profit Growth
Afya Ltd.
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue And Profit Growth